Categories: Health

Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+ Company

CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company (“Juice Plus+”), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world.

Mark A. LeDoux, NAI’s CEO and Chairman of the Board, said, “Continuing our 30+ year relationship with JuicePlus+ reflects our shared commitment to delivering premium nutritional products backed by extensive scientific research. Together, we remain focused on enhancing the health-promoting properties of the JuicePlus+ family of products.”

Travis Garza, Juice Plus+ CEO, said, “We are very pleased with our commercial relationship with NAI. Their commitment to quality and our global innovation plans has been impressive and consistent, and this contract extension recognizes the value of continuing these mutual efforts, and we are confident this extension will be mutually beneficial.”

NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to NAI’s clients including: scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see its website at http://www.nai-online.com.

This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, our expectations and beliefs with respect to the impact of this Agreement on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT – Michael Fortin, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@nai-online.com.

Web site: http://www.nai-online.com/

SOURCE Natural Alternatives International, Inc.

GlobeNews Wire

Recent Posts

Xinhua Silk Road: Int’l beer festival kicks off in ice and snow world of Harbin, NE China

BEIJING, July 8, 2026 /PRNewswire/ -- When the 24th Harbin International Beer Festival opened recently…

44 minutes ago

Xinhua Silk Road: Chinese baijiu maker Wuliangye’s World Cup campaigns spur off-season sales

BEIJING, July 8, 2026 /PRNewswire/ -- Leading Chinese baijiu maker Wuliangye has leveraged the FIFA…

44 minutes ago

Geely Preface TCR Claims Resounding Victory in France; Race-Honed Technology Drives Dual Breakthroughs Across Geely’s French Distribution Network and Product Lineup

LE CASTELLET, France, July 8, 2026 /PRNewswire/ -- Geely Group Motorsport and Geely Cyan Racing…

2 hours ago

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon…

4 hours ago

TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan

July 07, 2026 19:00 ET  | Source: TaiMed Biologics TAIPEI, July 07, 2026 (GLOBE NEWSWIRE)…

4 hours ago

Resmed Announces Agreement to Sell MatrixCare Business

SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading…

4 hours ago